{"transactions":[{"id":2022190,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-10T21:54:03.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":108000,"derivative":{"exercise_price":34.2,"expiration_date":"2033-02-08","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0000899243-23-004595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323004595/doc4.xml","form_type":"4"}},{"id":2052070,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":24853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":267000,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":24853},"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2052069,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":4147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":291853,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":4147},"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2052068,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":24853,"price":37.21,"value":924780.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2052067,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":24853,"price":23.03,"value":572364.59,"ownership":{"direct":true},"balance_after":24853,"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2052066,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":4147,"price":37.01,"value":153480.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2052065,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-18T22:58:22.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":4147,"price":23.03,"value":95505.41,"ownership":{"direct":true},"balance_after":4147,"source":{"system":"sec-edgar","filing":"0000899243-23-002075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323002075/doc4.xml","form_type":"4"}},{"id":2056261,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-10","kind":"exercise","acquired":false,"shares":47377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":296000,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":47377},"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2056260,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-09","kind":"exercise","acquired":false,"shares":12623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":343377,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":12623},"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2056259,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":47377,"price":35.3,"value":1672408.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.76 to $35.934. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2056258,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-10","kind":"exercise","acquired":true,"shares":47377,"price":23.03,"value":1091092.31,"ownership":{"direct":true},"balance_after":47377,"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2056257,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":12623,"price":33.04,"value":417063.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2056256,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-12T00:09:33.000Z","date":"2023-01-09","kind":"exercise","acquired":true,"shares":12623,"price":23.03,"value":290707.69,"ownership":{"direct":true},"balance_after":12623,"source":{"system":"sec-edgar","filing":"0000899243-23-001626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924323001626/doc4.xml","form_type":"4"}},{"id":2412968,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T23:13:44.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":18.51,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-22-004669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924322004669/doc4.xml","form_type":"4"}},{"id":2900242,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117035,"kind":"person","name":"Katz Barrett","position":1,"cik":"0001841628","reported_name":"Katz Barrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-22T00:33:57.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":356000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":356000,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":356000},"source":{"system":"sec-edgar","filing":"0000899243-21-002770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924321002770/doc4.xml","form_type":"4"}}]}